Table 2 Linear mixed-effects model for the change in cardiovascular biomarkers.

From: Cardiovascular Risk Comparison between Expanded Hemodialysis Using Theranova and Online Hemodiafiltration (CARTOON): A Multicenter Randomized Controlled Trial

Variables

Baseline values

Change from the baseline (mean and 95% confidence intervals)

6 months

P value

12 months

P value

baPWV (m/s)

HDx

1.8 ± 0.7

0.1 (0 to 0.2)

0.176

0 (− 0.1 to 0.2)

0.518

Online-HDF

1.9 ± 0.7

 − 0.1 (− 0.2 to 0)

0.221

0.1 (0 to 0.3)

0.046

Between-group difference

 

0.2 (0 to 0.3)

0.066

 − 0.1 (− 0.3 to 0.1)

0.317

LVEF (%)

HDx

63.0 (57.0–69.0)

 − 0.2 (− 2.5 to 2.1)

0.860

 − 0.7 (− 3.1 to 1.7)

0.561

Online-HDF

63.0 (56.0–66.0)

0.6 (–1.8 to 3.0)

0.622

 − 0.6 (− 3.1 to 1.9)

0.660

Between-group difference

 

 − 0.8 (− 4.1 to 2.6)

0.648

 − 0.1 (− 3.5 to 3.4)

0.966

LVMI (g/m2)

HDx

111.3 (88.7–138.9)

 − 36.1 (− 79.9 to 7.6)

0.106

 − 39.2 (− 84.0 to 5.5)

0.086

Online-HDF

114.7 (102.2–142.9)

 − 22.5 (− 69.8 to 24.8)

0.351

 − 54.7 (− 103.2 to − 6.1)

0.027

Between-group difference

 

 − 13.4 (− 77.7 to 50.8)

0.682

14.5 (− 51.4 to 80.4)

0.666

E/e

HDx

12.0 (10.0–16.0)

0.3 (− 1.0 to 1.7)

0.628

0.4 (− 1.0 to 1.8)

0.536

Online-HDF

12.8 (10.0–14.8)

 − 0.8 (− 2.3 to 0.6)

0.274

 − 0.2 (− 1.7 to 1.3)

0.815

Between-group difference

 

1.2 (− 0.8 to 3.2)

0.240

0.7 (− 1.4 to 2.7)

0.516

Coronary artery calcium score*

HDx

295 (19–799)

64.6 (0.7 to 128.5)

0.048

154.9 (91.0 to 218.8)

 < 0.001

Online-HDF

268 (16–678)

23.0 (− 43.1 to 89.1)

0.496

36.6 (− 29.5 to 102.7)

0.277

Between-group difference

 

41.6 (− 50.3 to 133.6)

0.375

118.3 (26.3 to 210.2)

0.012

  1. baPWV brachial-ankle pulse wave velocity, HDx expanded hemodialysis, HDF hemodiafiltration, LVEF left ventricular ejection fraction, LVMI left ventricular mass index, E peak early mitral inflow velocity, e′ peak early diastolic mitral annular velocity.
  2. *Available for 41 of the HDx group patients and 35 of the online-HDF group patients.